查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1316475

人类微生物组市场：依疾病、技术、产品、治疗领域、用途- 全球预测 2023-2030

Human Microbiome Market by Disease, Technology, Product, Therapeutic Area, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球人类微生物组市场预计将以23.78%的复合年增长率大幅成长，到2023年达到15.8771亿美元，到2030年将达到711869万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球人类微生物组市场至关重要。透过检验业务策略和产品满意度等关键指标，它可以对供应商进行全面评估，使用户能够根据自己的特定需求做出资讯的决策。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 人类微生物组的全球市场规模和预测是多少？

2.在预测期内，COVID-19 对全球人类微生物组市场的阻碍因素和影响为何？

3. 在预测期内，全球人类微生物组市场需要投资哪些产品/细分市场/应用/领域？

4. 全球人类微生物组市场的竞争策略为何？

5. 全球人类微生物组市场的技术趋势和法律规范是什么？

6.全球人类微生物组市场主要厂商的市占率是多少？

7. 哪些型态和策略措施被认为适合进入全球人类微生物组市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 进一步专注于开发人类微生物疗法
      • 药物研发、早期疾病检测和诊断的人类微生物组
      • 益生菌和婴儿营养对微生物组的需求不断增长
    • 抑制因素
      • 有关微生物组治疗的专业知识有限和安全问题
    • 机会
      • 增加合作和研究投资以创造成长机会
      • 新型人类微生物组疗法的开发
    • 任务
      • 了解细菌种类数量的限制以及基于人类微生物组的药物的不确定性
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化
    • 智慧财产权形势

第6章人类微生物组市场：依疾病分类

  • 急性腹泻
  • 自体免疫疾病
  • 癌症
  • 糖尿病
  • 精神障碍
  • 肥胖

第7章人类微生物组市场：依技术分类

  • 16s rRNA测序
  • 细胞培养技术
  • 计算工具
  • 高通量技术
  • 宏基因体定序
  • 组学技术

第8章人类微生物组市场：副产品

  • 诊断设备
  • 药品
  • 食品
  • 益生元和益生菌

第9章按治疗领域分類的人类微生物组市场

  • 胃肠道疾病
  • 代谢紊乱
  • 皮肤病
  • 女性健康

第10章人类微生物组市场：依用途

  • 诊断
  • 疗法

第11章美洲人类微生物组市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第12章亚太人类微生物组市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第13章欧洲、中东和非洲人类微生物组市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第15章上市公司名单

第16章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-430D42AA0FD7

The Global Human Microbiome Market is forecasted to grow significantly, with a projected USD 1,587.71 million in 2023 at a CAGR of 23.78% and expected to reach a staggering USD 7,118.69 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Human Microbiome Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Human Microbiome Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Disease, market is studied across Acute Diarrhea, Autoimmune Disorders, Cancer, Diabetes, Mental Disorders, and Obesity. The Autoimmune Disorders commanded largest market share of 23.66% in 2022, followed by Cancer.

Based on Technology, market is studied across 16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, Metagenomic Sequencing, and Omics Technology. The Cell Culture Technology commanded largest market share of 32.14% in 2022, followed by Computational Tools.

Based on Product, market is studied across Diagnostic Devices, Drugs, Foods, and Prebiotic & Probiotics. The Drugs commanded largest market share of 43.85% in 2022, followed by Prebiotic & Probiotics.

Based on Therapeutic Area, market is studied across Gastrointestinal Disorders, Metabolic Disorders, Skin Disorders, and Women's Health. The Gastrointestinal Disorders commanded largest market share of 30.08% in 2022, followed by Metabolic Disorders.

Based on Application, market is studied across Diagnostics and Therapeutics. The Therapeutics commanded largest market share of 54.10% in 2022, followed by Diagnostics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 40.03% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Human Microbiome Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Human Microbiome Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Microbiome Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Microbiome Market?

4. What is the competitive strategic window for opportunities in the Global Human Microbiome Market?

5. What are the technology trends and regulatory frameworks in the Global Human Microbiome Market?

6. What is the market share of the leading vendors in the Global Human Microbiome Market?

7. What modes and strategic moves are considered suitable for entering the Global Human Microbiome Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Human Microbiome Market, by Disease, 2022 vs 2030
  • 4.3. Human Microbiome Market, by Technology, 2022 vs 2030
  • 4.4. Human Microbiome Market, by Product, 2022 vs 2030
  • 4.5. Human Microbiome Market, by Therapeutic Area, 2022 vs 2030
  • 4.6. Human Microbiome Market, by Application, 2022 vs 2030
  • 4.7. Human Microbiome Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased Focus on Development of Human Microbiome Therapy
      • 5.1.1.2. Human Microbiome for Drug Discovery, Early Disease Detection, and Diagnosis
      • 5.1.1.3. Increasing Demand for Microbiome in Probiotics and Infant Nutrition
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Expertise and Safety Issue related to Microbiome Therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing Collaborations and Research Investments to Create Growth Opportunities
      • 5.1.3.2. Development of Novel Human Microbiome Therapeutic Products
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations in Understanding Number of Bacterial Species and Uncertainty of Human Microbiome-Based Drugs
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization
    • 5.9.1. Intellectual Property Landscape

6. Human Microbiome Market, by Disease

  • 6.1. Introduction
  • 6.2. Acute Diarrhea
  • 6.3. Autoimmune Disorders
  • 6.4. Cancer
  • 6.5. Diabetes
  • 6.6. Mental Disorders
  • 6.7. Obesity

7. Human Microbiome Market, by Technology

  • 7.1. Introduction
  • 7.2. 16s rRNA Sequencing
  • 7.3. Cell Culture Technology
  • 7.4. Computational Tools
  • 7.5. High-Throughput Technology
  • 7.6. Metagenomic Sequencing
  • 7.7. Omics Technology

8. Human Microbiome Market, by Product

  • 8.1. Introduction
  • 8.2. Diagnostic Devices
  • 8.3. Drugs
  • 8.4. Foods
  • 8.5. Prebiotic & Probiotics

9. Human Microbiome Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Gastrointestinal Disorders
  • 9.3. Metabolic Disorders
  • 9.4. Skin Disorders
  • 9.5. Women's Health

10. Human Microbiome Market, by Application

  • 10.1. Introduction
  • 10.2. Diagnostics
  • 10.3. Therapeutics

11. Americas Human Microbiome Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Human Microbiome Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Human Microbiome Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. HUMAN MICROBIOME MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN MICROBIOME MARKET SIZE, 2022 VS 2030
  • FIGURE 3. HUMAN MICROBIOME MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022 VS 2030 (%)
  • FIGURE 5. HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 6. HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 7. HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2030 (%)
  • FIGURE 8. HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 9. HUMAN MICROBIOME MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 10. HUMAN MICROBIOME MARKET DYNAMICS
  • FIGURE 11. HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. HUMAN MICROBIOME MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 21. HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. HUMAN MICROBIOME MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. HUMAN MICROBIOME MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 5. HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 24. HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. HUMAN MICROBIOME MARKET SIZE, BY WOMEN'S HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. HUMAN MICROBIOME MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 241. HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 242. HUMAN MICROBIOME MARKET LICENSE & PRICING